Skip to main content
SpringerLink
Log in

Seborrheic Dermatitis

  • Chapter
  • First Online:
Hair and Scalp Treatments

  • 1554 Accesses

Abstract

Seborrheic dermatitis (SD) is a chronic relapsing erythematous scaly disease with a prevalence of 1–3% in the general population. The exact etiology is unknown and multifactorial; the most accepted theory suggests that yeast of Malassezia spp. causes skin irritation and inflammation on the seborrheic areas in susceptible individuals. The clinical diagnosis is based on the location and appearance of the lesions. Treatment objective is to clear the signs of the disease, ameliorate the symptoms, and maintain remission with long-term therapy. Topical antifungal and anti-inflammatory agents are the first-line therapy. Systemic therapy is reserved only for severe or refractory cases, and alternative therapies have also been reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019;30:158–69.

    CAS  PubMed  Google Scholar 

  2. Sasseville D. Seborrheic dermatitis. In: Post TW, editor. UpToDate. Waltham, MA: UptoDate Inc. http://www.uptodate.com. Accessed on July 2018.

  3. Arenas R. Dermatologia Atlas, diagnóstico y tratamiento. 6th ed. New York: McGraw Hill Mexico; 2015. p. 65–70.

    Google Scholar 

  4. Cheong WK, Yeung CK, Torsekar RG, Suh DH, Ungpakorn R, Widaty S, et al. Treatment of seborrhoeic dermatitis in Asia: a consensus guide. Skin Appendage Disord. 2016;1(4):187–96.

    PubMed  PubMed Central  Google Scholar 

  5. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185–90.

    PubMed  Google Scholar 

  6. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2)

    Google Scholar 

  7. Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011;86(6):1061–71.

    PubMed  Google Scholar 

  8. Baumert C, Melo M, Vincent EC. Topical medications for seborrheic dermatitis. Am Fam Physician. 2017;95(5):329.

    PubMed  Google Scholar 

  9. Kamamoto CSL, Nishikaku AS, Gompertz OF, Melo AS, Hassun KM, Bagatin E. Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial. Dermatoendocrinol. 2017;9(1):e1361573.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev. 2015;5:CD008138.

    Google Scholar 

  11. Karakadze MA, Hirt PA, Wikramanayake TC. The genetic basis of seborrhoeic dermatitis: a review. J Eur Acad Dermatol Venereol. 2018;32(4):529–36.

    CAS  PubMed  Google Scholar 

  12. Mameri ACA, Carneiro S, Mameri LMA, Telles da Cunha JM, Ramos-E-Silva M. History of seborrheic dermatitis: conceptual and clinico-pathologic evolution. Skinmed. 2017;15(3):187–94.

    PubMed  Google Scholar 

  13. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343–51.

    PubMed  Google Scholar 

  14. Angiolella L, Carradori S, Maccallini C, Giusiano G, Supuran CT. Targeting Malassezia species for novel synthetic and natural antidandruff agents. Curr Med Chem. 2017;24(22):2392–412.

    CAS  PubMed  Google Scholar 

  15. Kastarinen H, Okokon EO, Verbeek JH. Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review. JAMA Dermatol. 2015;151(2):221–2.

    PubMed  Google Scholar 

  16. Tosti A. Dermoscopy of the hair and nails, vol. 115. 2nd ed. Boca Raton, FL: CRC Press; 2016.

    Google Scholar 

  17. Apasrawirote W, Udompataikul M, Rattanamongkolgul S. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis. J Med Assoc Thai. 2011;94(6):756–60.

    PubMed  Google Scholar 

  18. Dall’Oglio F, Lacarrubba F, Verzì AE, Micali G. Noncorticosteroid combination shampoo versus 1% ketoconazole shampoo for the management of mild-to-moderate seborrheic dermatitis of the scalp: results from a randomized, investigator-single-blind trial using clinical and trichoscopic evaluation. Skin Appendage Disord. 2016;1(3):126–30.

    PubMed  Google Scholar 

  19. Buechner SA. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. J Dermatolog Treat. 2014;25(3):226–31.

    CAS  PubMed  Google Scholar 

  20. Schwartz JR. Zinc pyrithione: a topical antimicrobial with complex pharmaceutics. J Drugs Dermatol. 2016;15(2):140–4.

    CAS  PubMed  Google Scholar 

  21. Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15(6):434–41.

    PubMed  Google Scholar 

  22. Barak-Shinar D, Green LJ. Scalp seborrheic dermatitis and dandruff therapy using a herbal and zinc pyrithione-based therapy of shampoo and scalp lotion. J Clin Aesthet Dermatol. 2018;11(1):26–31.

    PubMed  PubMed Central  Google Scholar 

  23. Kastarinen H, Oksanen T, Okokon EO, Kiviniemi VV, Airola K, Jyrkka J. et al., Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev. 2014;(5):CD009446.

    Google Scholar 

  24. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol. 1986;114(6):695–700.

    CAS  PubMed  Google Scholar 

  25. Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology. 1992;184(4):275–80.

    CAS  PubMed  Google Scholar 

  26. Youn HJ, Kim SY, Park M, Jung WH, Lee YW, Choe YB, et al. Efficacy and safety of cream containing climbazole/piroctone olamine for facial seborrheic dermatitis: a single- center, open-label split-face clinical study. Ann Dermatol. 2016;28(6):733–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Turlier V, Viode C, Durbise E, Bacquey A, LeJeune O, Oliveira Soares R, et al. Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: randomized controlled study. Dermatol Ther (Heidelb). 2014;4(1):43–59.

    Google Scholar 

  28. Braga PC, Dal Sasso M, Fonti E, Culici M. Antioxidant activity of bisabolol: inhibitory effects on chemiluminescence of human neutrophil bursts and cell-free systems. Pharmacology. 2009;83(2):110–5.

    CAS  PubMed  Google Scholar 

  29. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32–8.

    PubMed  PubMed Central  Google Scholar 

  30. Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology. 1997;90(1):115–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Schmidt-Rose T, Braren S, Folster H, Hillemann T, Oltrogge B, Philipp P, et al. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci. 2011;33(3):276–82.

    CAS  PubMed  Google Scholar 

  32. Kim Y, Alpmann P, Blaum-Feder S, Kramer S, Endo T, Lu D, et al. Increased in vivo efficacy of lenalidomide by addition of piroctone olamine. In Vivo. 2011;25(1):99–103.

    CAS  PubMed  Google Scholar 

  33. Elewski B. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. Clin Dermatol. 2009;27(6 Suppl):S48–53.

    PubMed  Google Scholar 

  34. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci. 2005;62(22):2549–59.

    CAS  PubMed  Google Scholar 

  35. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008–12.

    CAS  PubMed  Google Scholar 

  36. Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol. 2004;3(4):427–31.

    PubMed  Google Scholar 

  37. Garcia RL, Miller JD, Miller WN. Occlusive tar extract therapy for recalcitrant psoriasis and seborrheic dermatitis of the scalp. Cutis. 1978;22(1):90–1.

    CAS  PubMed  Google Scholar 

  38. Piérard-Franchimont C, Piérard GE, Vroome V, Lin GC, Appa Y. Comparative anti-dandruff efficacy between a tar and a non-tar shampoo. Dermatology. 2000;200(2):181–4.

    PubMed  Google Scholar 

  39. Veien NK, Pilgaard CE, Gade M. Seborrhoeic dermatitis of the scalp treated with a tar/zinc pyrithione shampoo. Clin Exp Dermatol. 1980;5(1):53–6.

    CAS  PubMed  Google Scholar 

  40. Goldman WJ. Carcinogenicity of coal-tar shampoo. Lancet. 1995;345(8945):326.

    CAS  PubMed  Google Scholar 

  41. Seite S, Rougier A, Talarico S. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis. J Cosmet Dermatol. 2009;8(4):249–53.

    PubMed  Google Scholar 

  42. Emtestam L, Svensson A, Rensfeldt K. Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double- blind, randomised, placebo-controlled studies. Mycoses. 2012;55(5):393–403.

    CAS  PubMed  Google Scholar 

  43. Van Weelden H, De La Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119(1):11–9.

    PubMed  Google Scholar 

  44. Honig B, Morison WL, Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol. 1994;31(5 Pt 1):775–90.

    CAS  PubMed  Google Scholar 

  45. Herzinger T, Berneburg M, Ghoreschi K, Gollnick H, Holzle E, Honigsmann H, et al. S1- Guidelines on UV phototherapy and photochemotherapy. J Dtsch Dermatol Ges. 2016;14(8):853–76.

    PubMed  Google Scholar 

  46. Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000;143(5):964–8.

    CAS  PubMed  Google Scholar 

  47. Ghodsi SZ, Abbas Z, Abedeni R. Efficacy of oral itraconazole in the treatment and relapse prevention of moderate to severe seborrheic dermatitis: a randomized, placebo- controlled trial. Am J Clin Dermatol. 2015;16(5):431–7.

    PubMed  Google Scholar 

  48. Das J, Majumdar M, Chakraborty U, Majumdar V, Mazumdar G, Nath J. Oral itraconazole for the treatment of severe seborrhoeic dermatitis. Indian J Dermatol. 2011;56(5):515–6.

    PubMed  PubMed Central  Google Scholar 

  49. Shemer A, Kaplan B, Nathansohn N, Grunwald MH, Amichai B, Trau H. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study. Isr Med Assoc J. 2008;10(6):417–8.

    PubMed  Google Scholar 

  50. Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(1):16–26.

    CAS  PubMed  Google Scholar 

  51. Abbas Z, Ghodsi SZ, Abedeni R. Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial. Dermatol Pract Concept. 2016;6(3):11–6.

    PubMed  PubMed Central  Google Scholar 

  52. Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18(4):745–53.

    CAS  PubMed  Google Scholar 

  53. Cassano N, Amoruso A, Loconsole F, Vena GA. Oral terbinafine for the treatment of seborrheic dermatitis in adults. Int J Dermatol. 2002;41(11):821–2.

    PubMed  Google Scholar 

  54. Scaparro E, Quadri G, Virno G, Orifici C, Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol. 2001;144(4):854–7.

    CAS  PubMed  Google Scholar 

  55. Zisova LG. Fluconazole and its place in the treatment of seborrheic dermatitis--new therapeutic possibilities. Folia Med (Plovdiv). 2006;48(1):39–45.

    Google Scholar 

  56. Zisova LG. Treatment of Malassezia species associated seborrheic blepharitis with fluconazole. Folia Med (Plovdiv). 2009;51(3):57–9.

    Google Scholar 

  57. Comert A, Bekiroglu N, Gurbuz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007;8(4):235–8.

    PubMed  Google Scholar 

  58. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol. 1984;111(5):603–7.

    CAS  PubMed  Google Scholar 

  59. Odds F, Ausma J, Van Gerven F, Woestenborghs F, Meerpoel L, Heeres J, et al. In vitro and in vivo activities of the novel azole antifungal agent r126638. Antimicrob Agents Chemother. 2004;48(2):388–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Vanden Bossche H, Ausma J, Bohets H, Vermuyten K, Willemsens G, Marichal P, et al. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004;48(9):3272–8.

    CAS  Google Scholar 

  61. Pierard GE, Ausma J, Henry F, Vroome V, Wouters L, Borgers M, et al. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. Dermatology. 2007;214(2):162–9.

    CAS  PubMed  Google Scholar 

  62. Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006;126(10):2154–6.

    CAS  PubMed  Google Scholar 

  63. Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM. Isotretinoin temporally regulates distinct sets of genes in patient skin. J Invest Dermatol. 2009;129(4):1038–42.

    CAS  PubMed  Google Scholar 

  64. King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis- retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107(5):583–90.

    CAS  PubMed  Google Scholar 

  65. Rademaker M. Low-dose isotretinoin for seborrhoeic dermatitis. J Cutan Med Surg. 2017;21(2):170–1.

    PubMed  Google Scholar 

  66. de Souza Leão Kamamoto C, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. Int J Dermatol. 2017;56(1):80–5.

    PubMed  Google Scholar 

  67. Hashemi SA, Madani SA, Abediankenari S. The review on properties of Aloe Vera in healing of cutaneous wounds. Biomed Res Int. 2015;2015:714216.

    PubMed  PubMed Central  Google Scholar 

  68. Rosca-Casian O, Parvu M, Vlase L, Tamas M. Antifungal activity of Aloe vera leaves. Fitoterapia. 2007;78(3):219–22.

    PubMed  Google Scholar 

  69. Tollesson A, Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br J Dermatol. 1993;129(1):95.

    CAS  PubMed  Google Scholar 

  70. Tollesson A, Frithz A, Stenlund K. Malassezia furfur in infantile seborrheic dermatitis. Pediatr Dermatol. 1997;14(6):423–5.

    CAS  PubMed  Google Scholar 

  71. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A. A review of applications of tea tree oil in dermatology. Int J Dermatol. 2013;52(7):784–90.

    CAS  PubMed  Google Scholar 

  72. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 2002;47(6):852–5.

    PubMed  Google Scholar 

  73. Nenoff P, Haustein UF, Brandt W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol. 1996;9(6):388–94.

    CAS  PubMed  Google Scholar 

  74. Diehl C, Ferrari A. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis: a randomized, double-blind, comparative study. J Drugs Dermatol. 2013;12(3):312–5.

    PubMed  Google Scholar 

  75. Herrera-Arellano A, Jimenez-Ferrer E, Vega-Pimentel AM, Martinez-Rivera Mde L, Hernandez-Hernandez M, Zamilpa A, et al. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. Planta Med. 2004;70(6):483–8.

    CAS  PubMed  Google Scholar 

  76. Caspeta L, Nieto I, Zamilpa A, Alvarez L, Quintero R, Villarreal ML. Solanum chrysotrichum hairy root cultures: characterization, scale-up and production of five antifungal saponins for human use. Planta Med. 2005;71(11):1084–7.

    CAS  PubMed  Google Scholar 

  77. Smith SA, Baker AE, Williams JH. Effective treatment of seborrheic dermatitis using a low dose, oral homeopathic medication consisting of potassium bromide, sodium bromide, nickel sulfate, and sodium chloride in a double-blind, placebo-controlled study. Altern Med Rev. 2002;7(1):59–67.

    PubMed  Google Scholar 

  78. Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C selenium; zinc; iron. World Rev Nutr Diet. 1988;55:165–82.

    CAS  PubMed  Google Scholar 

  79. Schwartz JR, Marsh RG, Draelos ZD. Zinc and skin health: overview of physiology and pharmacology. Dermatol Surg. 2005;31(7 Pt 2):837–47.

    CAS  PubMed  Google Scholar 

  80. Nisenson A, Barness LA. Treatment of seborrheic dermatitis with biotin and vitamin B complex. J Pediatr. 1972;81(3):630–1.

    CAS  PubMed  Google Scholar 

  81. Keipert JA. Oral use of biotin in seborrhoeic dermatitis of infancy: a controlled trial. Med J Aust. 1976;1(16):584–5.

    CAS  PubMed  Google Scholar 

  82. Fabbrocini G, Cantelli M, Monfrecola G. Topical nicotinamide for seborrheic dermatitis: an open randomized study. J Dermatolog Treat. 2014;25(3):241–5.

    CAS  PubMed  Google Scholar 

  83. Nakayama J. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream. Eur J Dermatol. 2000;10(7):528–32.

    CAS  PubMed  Google Scholar 

  84. Pierard GE, Pierard-Franchimont C. Effect of a topical erythromycin-zinc formulation on sebum delivery. Evaluation by combined photometric-multi-step samplings with Sebutape. Clin Exp Dermatol. 1993;18(5):410–3.

    CAS  PubMed  Google Scholar 

  85. Shuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. Arch Dermatol. 2005;141(1):47–52.

    CAS  PubMed  Google Scholar 

  86. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004;43 Suppl 1:17–20.

    PubMed  Google Scholar 

  87. Reygagne P, Poncet M, Sidou F, Soto P. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis. 2007;79(5):397–403.

    PubMed  Google Scholar 

  88. O’Connor NR, McLaughlin MR, Ham P. Newborn skin. I Common rashes. Am Fam Physician. 2008;77(1):47–52.

    PubMed  Google Scholar 

  89. Brodell RT, Patel S, Venglarcik JS, Moses D, Gemmel D. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol. 1998;15(5):406–7.

    CAS  PubMed  Google Scholar 

  90. David E, Tanuos H, Sullivan T, Yan A, Kircik LH. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis). J Drugs Dermatol. 2013;12(4):448–52.

    CAS  PubMed  Google Scholar 

  91. Wannanukul S, Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thail. 2004;87(suppl 2):S68–71.

    Google Scholar 

  92. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13–26.

    CAS  PubMed  Google Scholar 

  93. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132(3):441–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National University of Mexico, Department of Onco-dermatology and Trichology Clinic, Mexico City, Mexico

    Daniel Asz-Sigall

  2. Fredric Brandt Endowed Professor of Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

    Antonella Tosti

Authors
  1. Daniel Asz-Sigall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonella Tosti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fredric Brandt Endowed, Professor of Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

    Antonella Tosti

  2. Dermatoncology & Trichology Clinic, National University of Mexico, Mexico City, Mexico

    Daniel Asz-Sigall

  3. Department of Dermatology, Santa Casa da Misericordia, Rio De Janeiro, Brazil

    Rodrigo Pirmez

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Asz-Sigall, D., Tosti, A. (2020). Seborrheic Dermatitis. In: Tosti, A., Asz-Sigall, D., Pirmez, R. (eds) Hair and Scalp Treatments. Springer, Cham. https://doi.org/10.1007/978-3-030-21555-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21555-2_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21554-5

  • Online ISBN: 978-3-030-21555-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation